Details of the Drug

General Information of Drug (ID: DMJONRK)

• Drug Name: EIDD-1931
• Synonyms: N-hydroxycytidine; NHC; NSC-529856; CTK0I1923; DTXSID70326527; NSC529856; SCHEMBL6674536

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[1]

• Affected Organisms: Influenza VirusSARS-CoVSARS-CoV-2
• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C9H13N3O6
  Canonical SMILES: C1=CN(C(=O)N=C1NO)C2C(C(C(O2)CO)O)O
  InChI: 1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1
  InChIKey: XCUAIINAJCDIPM-XVFCMESISA-N
• Cross-matching ID:
  PubChem CID: 197020
  CAS Number: 3258-02-4
  UNII: C3D11PV2O4
  DrugBank ID: DB15660
  TTD ID: D01SVO

References

• [1] An Orally Bioavailable Broad-Spectrum Antiviral Inhibits SARS-CoV-2 in Human Airway Epithelial Cell Cultures and Multiple Coronaviruses in Mice. Sci Transl Med. 2020 Apr 6;eabb5883.